Standout Papers

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients ... 2003 2026 2010 2018 2.2k
  1. Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma (2003)
    Nicholas J. Vogelzang, James J. Rusthoven et al. Journal of Clinical Oncology
  2. Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy (2004)
    Nasser H. Hanna, Frances A. Shepherd et al. Journal of Clinical Oncology

Immediate Impact

8 by Nobel laureates 20 from Science/Nature 79 standout
Sub-graph 1 of 20

Citing Papers

Selpercatinib in Patients With RET Fusion–Positive Non–Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial
2022 Standout
Evaluating eligibility criteria of oncology trials using real-world data and AI
2021 StandoutNature
1 intermediate paper

Works of Paolo Paoletti being referenced

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
2004 Standout

Author Peers

Author Last Decade Papers Cites
Paolo Paoletti 4863 408 825 2344 903 67 6.6k
Leonard M. Schuman 2616 384 544 4420 652 76 7.8k
Jihyoun Jeon 1675 305 710 1307 298 96 3.3k
Karen H. Antman 3227 81 392 3425 1186 144 8.3k
Martin C. Tammemägi 4580 106 331 2842 620 125 6.7k
Pierre R. Band 1285 521 1573 1892 825 125 6.2k
Anders Mellemgaard 4490 154 257 4034 1911 141 7.4k
W. J. Blot 2075 481 346 1053 865 52 5.8k
J F Fraumeni 1757 298 284 1623 1166 48 6.9k
Давид Заридзе 1342 608 362 1354 1682 124 5.5k
Rosangela Filiberti 1902 123 195 1366 521 99 4.1k

All Works

Loading papers...

Rankless by CCL
2026